Avastin Boosted Survival for Type of Aggressive Breast Cancer: Study (HealthDay)

Your Health Matters

HealthDay – WEDNESDAY, Dec. 7 (HealthDay News) — In November, the U.S. Food and
Drug Administration revoked its approval of the drug Avastin for the
treatment of breast cancer. But, a new study suggests that the drug can
boost the survival of women with a specific type of aggressive breast
tumor when used in conjunction with two other medications.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave